Fertility preservation in transgender patients

@article{Jones2016FertilityPI,
  title={Fertility preservation in transgender patients},
  author={C A Jones and Laura Reiter and Ellen M. Greenblatt},
  journal={International Journal of Transgenderism},
  year={2016},
  volume={17},
  pages={76 - 82}
}
ABSTRACT Fertility preservation is an important consideration for transgender people prior to initiating cross-sex hormones or undergoing sex reassignment surgery. We performed a retrospective chart review identifying all transgender patients referred for fertility preservation at one university-affiliated fertility clinic from November 2011 to March 2014. Eleven male-to-female (MtF) transgender patients and 3 female-to-male (FtM) transgender patients were seen for sperm banking or fertility… 

Fertility Preservation for Transgender Adolescents.

Systematic review of fertility preservation options in transgender patients: a guide for plastic surgeons.

A systematic review of English, Spanish, Chinese, French and Turkish languages from 2000 to December 23rd, 2019, using the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) guidelines, found 15 articles that report outcomes of fertility preservation options in transgenders.

Fertility Preservation for the Transgender Individual

FP is an important option for transgender patients who desire to retain the ability to become genetic parents and while controlled ovarian stimulation for oocyte or embryo cryopreservation is the standard-of-care for transmen, unique considerations must be made in this population.

Fertility preservation options in transgender people: A review

Fertility preservation options should be discussed with all transpeople before medical and surgical transition and experimental techniques including spermatogonium stem cells (SSC) and testicular tissue preservation are technologies currently under development in prepubertal individuals but are not yet clinically available.

Transgender men's experiences of fertility preservation: a qualitative study

The results show that transgender men's experience of FP places may elicit gender incongruence and gender dysphoria, however, health care personnel can alleviate distress by using a gender-neutral language and the preferred pronoun.

Options for Fertility Treatments for Trans Women in Germany

Options of fertility preservation in trans women are reviewed based on recent publications on testicular regression at the time of gender confirming surgery demonstrating presence of sperm or at least spermatogonia in the majority of tissues and standardized urological procedures and experimental approaches are considered.

Fertility desires and reproductive needs of transgender people: Challenges and considerations for clinical practice

The goal of this review was to summarize the available evidence on the fertility desires and parental roles of transgender and gender nonconforming people and provide some considerations for clinical practice and suggest further areas of research.

Fertility preservation for transgender adolescents and young adults: a systematic review.

From a synthesis of the literature, it is concluded that there are many barriers preventing TAYAs from pursuing FP, including a lack of awareness of FP options, high costs, invasiveness of the available procedures and the potential psychological impact of the FP process.

References

SHOWING 1-10 OF 38 REFERENCES

Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer

The first case report of a female-to-male (FtM) transgender patient to undergo oocyte cryopreservation before initiating androgen therapy is presented.

Reproductive wish in transsexual men.

The data reveal that the majority of transsexual men desire to have children, and more attention should be paid to this topic during the diagnostic phase of transition and to the consequences for genetic parenthood after starting sex reassignment therapy.

Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people.

This paper argues that transsexual people should be offered the same options as any person that risks losing their germ cells because of treatment for a malignant disease and the option of gamete banking should be discussed before starting hormonal and surgical reassignment treatment.

Transgender Men Who Experienced Pregnancy After Female-to-Male Gender Transitioning

Transgender men are achieving pregnancy after having socially, medically, or both transitioned and themes from this study can be used to develop transgender-appropriate services and interventions that may improve the health and health care experiences of transgender men.

Feasibility of fertility preservation in young females with Turner syndrome.

Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).

Interestingly, testicular histology was highly heterogeneous irrespective of the treatment strategy, a phenomenon that requires further investigation.

Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.

After careful evaluation of the surgical risks, ovarian tissue cryopreservation can be proposed as an efficient option to preserve the fertility of children and young adults facing gonadotoxic therapies, however, alternative procedures such as oocyte or embryo cryop Reservation should be considered as first options.

The female-to-male transsexual patient: a source of human ovarian cortical tissue for experimental use.

It is demonstrated that ovaries removed from female-to-male transsexuals can be used as research material for ovarian cryopreservation, grafting and culture studies, and maybe even for oocyte donation in the future.

Autotransplantation of cryopreserved ovarian tissue – effective method of fertility preservation in cancer patients

Cryopreservation of ovarian tissue has unique advantages over other strategies and does not delay cancer treatment, is safer for hormone dependent malignancy, can be done independent of menstrual cycles and is the only option for prepubertal girls.

Histopathology of the testes from male transsexuals on oestrogen therapy.

It is suggested that the observed histological features are due to refractoriness to oestrogens, and the iatrogenic effects of oestrogen superimposed on normal or altered hypoathalamo-pituitary function.